北京泰舟利泽

Taizhou Lize (Beijing) Pharmaceutical Technology is a professional contract research organization (CRO) based in China that provides comprehensive services for pharmaceutical and medical device development. The company specializes in clinical trial management, regulatory affairs, and technical consulting to facilitate the registration and market entry of healthcare products. With a focus on compliance and quality, Taizhou Lize supports clients through various stages of the drug development lifecycle, including Phase I through Phase IV clinical trials. The firm leverages its expertise in the Chinese regulatory environment to help domestic and international companies navigate complex approval processes with the National Medical Products Administration (NMPA). Its service portfolio is designed to optimize research efficiency and ensure adherence to international standards such as Good Clinical Practice (GCP).